
TY  - JOUR
TI  - American Society for Laser Medicine and Surgery thirteenth annual meeting New Orleans, Louisiana abstracts
JO  - Lasers in Surgery and Medicine
JA  - Lasers Surg. Med.
VL  - 13
IS  - S5
SN  - 0196-8092
UR  - https://doi.org/10.1002/lsm.1900130702
DO  - doi:10.1002/lsm.1900130702
SP  - 1
EP  - 77
PY  - 1993
ER  - 

TY  - JOUR
TI  - Posters Session 1, Sunday 18 September
JO  - European Journal of Neurology
VL  - 12
IS  - s2
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2005.01308.x
DO  - doi:10.1111/j.1468-1331.2005.01308.x
SP  - 37
EP  - 300
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Clinical Endocrinology
JA  - Clin Endocrinol
VL  - 89
IS  - S1
SN  - 0300-0664
UR  - https://doi.org/10.1111/cen.13727
DO  - doi:10.1111/cen.13727
SP  - 4
EP  - 94
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 20
IS  - 10
SN  - 0277-0008
UR  - https://doi.org/10.1592/phco.20.15.1229.34588
DO  - doi:10.1592/phco.20.15.1229.34588
SP  - 1229
EP  - 1301
PY  - 2000
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Movement Disorders
JA  - Mov Disord.
VL  - 34
IS  - S2
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.27795
DO  - doi:10.1002/mds.27795
SP  - S1
EP  - S930
PY  - 2019
ER  - 

TY  - JOUR
TI  - APSSM ABSTRACTS
JO  - The Journal of Sexual Medicine
VL  - 7
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2010.01757.x
DO  - doi:10.1111/j.1743-6109.2010.01757.x
SP  - 70
EP  - 111
PY  - 2010
ER  - 

TY  - JOUR
TI  - Posters
JO  - Diabetic Medicine
VL  - 25
IS  - s1
SN  - 0742-3071
UR  - https://doi.org/10.1111/j.1464-5491.2008.02388.x
DO  - doi:10.1111/j.1464-5491.2008.02388.x
SP  - 34
EP  - 162
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Epilepsia
JA  - Epilepsia
VL  - 55
IS  - s2
SN  - 0013-9580
UR  - https://doi.org/10.1111/epi.12675
DO  - doi:10.1111/epi.12675
SP  - 4
EP  - 246
PY  - 2014
ER  - 

TY  - JOUR
TI  - Table of Contents
JO  - The Brown University Geriatric Psychopharmacology Update
JA  - Ger. Psych. Update
VL  - 11
IS  - 4
SN  - 1529-2584
UR  - https://doi.org/10.1002/gpu.20041
DO  - doi:10.1002/gpu.20041
SP  - 1
EP  - 8
PY  - 2007
AB  - Abstract Parkinson's disease drugs implicated in cardiac-valve regurgitation Daily SSRI use increases fracture risk in older population Neuroleptic malignant syndrome and risperidone Once-daily versus twice-daily effects of memantine in AD patients at a glance? Commentary on 5-HT2B agonists: Joseph H. Friedman, M.D. Citalopram and venlafaxine associated with syndrome of inappropriate secretion of diuretic hormone (SIADH) New U.S. data on common neurological disorders New approvals
ER  - 

AU  - Wilson, Deborah V.
AU  - Shih, André C.
C7  - pp. 114-129
TI  - Anesthetic Emergencies and Resuscitation
SN  - 9781118526231
UR  - https://doi.org/10.1002/9781119421375.ch5
DO  - doi:10.1002/9781119421375.ch5
SP  - 114-129
KW  - anesthesia
KW  - cardiac dysrhythmias
KW  - cardiopulmonary resuscitation
KW  - corticosteroids
KW  - hypotension
KW  - hypoxia
KW  - tachycardia
PY  - 2007
AB  - Summary Anesthesia is a very complex, dynamic domain that is labor intensive, can be equipment intensive, and requires accuracy and attention to detail for a good outcome. Errors and unforeseen events occur with low frequency, catastrophic events usually cannot be predicted, and mistakes are not always reversible. Derangements of cardiovascular function occur commonly in most species under anesthesia. Treatment of hypotension should be aimed at the probable cause, but generally should start with a reduction in anesthetic depth and a fluid bolus. Cardiac dysrhythmias occur in >60% of human patients undergoing anesthesia and surgery, and seem as prevalent in animal patients. Treatment involves correcting any obvious physiologic abnormalities (low pH, hypercarbia, hypoxia, electrolyte derangements such as low K+) and administering antiarrhythmic drugs (e.g., lidocaine or procainamide). When tachycardia, arrhythmias, and hypotension are present, oxygen, IV fluids, IV antihistamines (diphenhydramine), and corticosteroids are indicated for treatment and occasionally epinephrine and cardiopulmonary resuscitation (CPR) will be necessary.
ER  - 

TY  - JOUR
AU  - Belew, Daniel
AU  - Klaassen, Zachary
AU  - Lewis, Ronald W.
TI  - Intracavernosal Injection for the Diagnosis, Evaluation, and Treatment of Erectile Dysfunction: A Review
JO  - Sexual Medicine Reviews
JA  - Sexual Medicine Reviews
VL  - 3
IS  - 1
SN  - 9781118526231
UR  - https://doi.org/10.1002/smrj.35
DO  - doi:10.1002/smrj.35
SP  - 11
EP  - 23
KW  - Erectile Dysfunction
KW  - Intracavernosal Injection
KW  - Penile Doppler Ultrasound
KW  - Radical Prostatectomy
PY  - 2015
AB  - Abstract Introduction Intracavernosal injection (ICI) of a vasoactive agent has been an important part of the diagnosis, evaluation, and treatment of erectile dysfunction (ED) since its initial description by Virag in 1982. Aim To review the literature and summarize the use of ICI and its role in the diagnosis, evaluation, and treatment of ED. Methods Literature review. Main Outcome Measure To define the role of ICI's utility in the diagnosis, evaluation, and treatment of ED. Results When used in conjunction with color penile Doppler ultrasound for ED evaluation and diagnosis, ICI helps to detect penile vascular abnormalities and allows for differentiation between the multiple vasculogenic causes of impotence, thus helping clinicians to select the optimal treatment modality for each patient. Patients utilizing ICI continue to report high efficacy and satisfaction rates relative to other treatment options despite ICI's designation as a second-line therapy since the introduction of oral phosphodiesterase type 5 inhibitors in 1998. In recent years, ICI has also become an important part of penile rehabilitation programs following radical prostatectomy, as regular use of ICI is thought to increase the rate at which patients experience return of spontaneous erection through preservation of penile tissue integrity and prevention of corporeal smooth muscle atrophy. Conclusions ICI of vasoactive agents remains an important tool in treating and diagnosing ED, with high patient satisfaction and efficacy rates. However, the dropout rate for ICI therapy remains relatively high, and it may be associated with priapism, ecchymoses, hematoma formation, and penile fibrosis. Patients should be educated on the benefits and limitations of ICI therapy prior to beginning treatment in order to minimize dropout rates. Additional studies are necessary to better understand the possible long-term benefits of ICI therapy and how to most effectively structure the penile rehabilitation program after radical prostatectomy. Belew D, Klaassen Z, and Lewis RW. Intracavernosal injection for the diagnosis, evaluation, and treatment of erectile dysfunction: A review. Sex Med Rev 2015;3:11?23.
ER  - 

TY  - JOUR
TI  - Posters
JO  - Clinical Microbiology and Infection
VL  - 15
IS  - s4
SN  - 9781118526231
UR  - https://doi.org/10.1111/j.1469-0691.2009.02858.x
DO  - doi:10.1111/j.1469-0691.2009.02858.x
SP  - S107
EP  - S612
PY  - 2009
ER  - 

TY  - JOUR
TI  - Concurrent Session
JO  - The Journal of Dermatology
VL  - 39
IS  - s1
SN  - 9781118526231
UR  - https://doi.org/10.1111/j.1346-8138.2012.01623.x
DO  - doi:10.1111/j.1346-8138.2012.01623.x
SP  - 12
EP  - 52
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts from the International Veterinary Emergency and Critical Care Symposium and the European Veterinary Emergency and Critical Care Society Annual Congress, 2011
JO  - Journal of Veterinary Emergency and Critical Care
JA  - Journal of Veterinary Emergency and Critical Care
VL  - 21
IS  - s1
SN  - 9781118526231
UR  - https://doi.org/10.1111/j.1476-4431.2011.00660.x
DO  - doi:10.1111/j.1476-4431.2011.00660.x
SP  - S1
EP  - S26
PY  - 2011
ER  - 

TY  - JOUR
TI  - DrugScan Series
JO  - Journal of Pharmacy Practice and Research
JA  - Journal of Pharmacy Practice and Research
VL  - 41
IS  - 1
SN  - 9781118526231
UR  - https://doi.org/10.1002/j.2055-2335.2011.tb00070.x
DO  - doi:10.1002/j.2055-2335.2011.tb00070.x
SP  - 62
EP  - 72
PY  - 2011
AB  - This review brings you up-to-date with the international literature on therapeutics. Leading pharmacy practitioners scan major peer-reviewed journals in areas relevant to Australian pharmacy practice and present precis on major clinical trials, important pharmacoepidemiology studies, and pharmacoeconomic research. Interested readers are encouraged to explore the original publications in greater detail.
ER  - 

TY  - JOUR
TI  - Specialised Systems Pharmacology
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 115
IS  - s1
SN  - 9781118526231
UR  - https://doi.org/10.1111/bcpt.12259_14
DO  - doi:10.1111/bcpt.12259_14
SP  - 339
EP  - 349
PY  - 2014
ER  - 

TY  - JOUR
TI  - ASBMR 2010 Annual Meeting SU0001–SU0482
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 25
IS  - S1
SN  - 9781118526231
UR  - https://doi.org/10.1002/jbmr.5650251304
DO  - doi:10.1002/jbmr.5650251304
SP  - S225
EP  - S362
PY  - 2010
ER  - 

TY  - JOUR
TI  - Index Volumes to 459_474-481
JO  - The Journal of Physiology
VL  - 481
IS  - index
SN  - 9781118526231
UR  - https://doi.org/10.1113/jphysiol.1995.sp020411
DO  - doi:10.1113/jphysiol.1995.sp020411
SP  - 103
EP  - 162
PY  - 1995
ER  - 

AU  - Tedeschi, C. G.
C7  - pp. 141-168
TI  - Pathological anatomy of adipose tissue1
UR  - https://doi.org/10.1002/cphy.cp050114
DO  - doi:10.1002/cphy.cp050114
SP  - 141-168
PY  - 1995
AB  - Abstract The sections in this article are:
ER  - 

TY  - JOUR
AU  - Monafo, William W.
AU  - Moyer, Carl A.
TI  - THE TREATMENT OF EXTENSIVE THERMAL BURNS WITH 0.5% SILVER NITRATE SOLUTION*
JO  - Annals of the New York Academy of Sciences
VL  - 150
IS  - 3
UR  - https://doi.org/10.1111/j.1749-6632.1968.tb14745.x
DO  - doi:10.1111/j.1749-6632.1968.tb14745.x
SP  - 937
EP  - 945
PY  - 1968
ER  - 
